Beijing to Let Some Low-Risk Patients Home Quarantine as Covid Soars + Some Notes

December 1, 2022December 1, 2022 Tina Marie (Ms. Cat)1 Comment

Bloomberg: Beijing to Let Some Low-Risk Patients Home Quarantine as Covid Soars

Global Times: Flexible measures implemented across China to ensure people’s livelihoods amid cold front

China actually started relaxing it’s Zero-COVID polices on November 11th. The mNRA vaccine hasn’t been approved, yet. The West is pushing for China to use mNRA vaccines.

China’s refusal to use Western COVID-19 vaccines is making its protest problems even worse

New COVID Booster Approved From Final Study of Mice, Not Humans, But Using Only Animal Data Is a Needless Gamble

September 10, 2022September 10, 2022 Tina Marie (Ms. Cat)

VERIFY: New COVID booster approved from final study of mice, not humans

According to documents on the CDC website, human tests of Moderna’s version of the new booster are still “ongoing.” Right now, there is only final evidence from “8-10 mice” per group.”

The FDA’s website shows for Pfizer the agency also relayed on the final study evidence from “8 mice.” But human trials are also ongoing. So far, the new boosters “showed a similar local reaction and systemic event profile.” That means side effects appear to be about the same including “mild to moderate injection site pain, fatigue, and muscle pain.”

…

“To advance the Omicron BA.4/BA.5 bivalent vaccine as rapidly as possible, regulators, including the FDA, WHO and EMA, have advised that our submissions be based on safety and immunogenicity data generated in adults with an Omicron BA.1 bivalent vaccine and supported by BA.4/BA.5 bivalent pre-clinical data and BA.4/BA.5 bivalent quality and manufacturing data. These packages follow a similar model to that provided to public health officials who evaluate seasonal flu vaccines each year. Moving forward, this approach may help address the pressing need for vaccines that provide a high level of protection against current and emerging variants of concern so that we can remain vigilant against this evolving virus. The FDA has authorized our Omicron BA.4/BA.5 bivalent vaccine based on clinical data generated in adults with an Omicron BA.1 bivalent vaccine, pre-clinical data with a BA.4/BA.5 bivalent vaccine and BA.4/BA.5 bivalent quality and manufacturing data. Pre-clinical data showed a booster dose of Pfizer and BioNTech’s Omicron BA.4/BA.5- bivalent vaccine generated a strong neutralizing antibody response against Omicron BA.1, BA.2 and BA.4/BA.5 variants, as well as the original wild-type strain. A clinical study investigating the safety, tolerability and immunogenicity of the Omicron BA.4/BA.5 bivalent vaccine in individuals 12 years of age and older is ongoing. Data will be shared with regulators when available. We are facing a virus with an exceptionally high mutation rate, which the nimble mRNA platform is well situated to address. Only the mRNA sequence requires updating to match emerging strains, and utilizing a bivalent vaccine aims to provide broader coverage against known and future COVID-19 variants of concern.”

Related:

Pfizer Jab Fails It’s CEO, Albert Bourla

August 15, 2022August 15, 2022 Tina Marie (Ms. Cat)1 Comment

The jab that failed on all counts BUT one.

…

The top executive at Pfizer, a leading producer of COVID-19 vaccines, has tested positive for the virus and says he is experiencing very mild symptoms.

Chairman and CEO Albert Bourla said Monday that he started taking Pfizer´s Paxlovid pill treatment and is isolating while he recovers.
Pfizer Jab Fails It’s CEO, Albert Bourla

Waiting for the Paxlovid Rebound…

DOUBLE-BOOSTED Fauci’s Covid WORSENS After Paxlovid Rebound.

June 30, 2022June 30, 2022 Tina Marie (Ms. Cat)

Fauci first tested positive after having a “scratchy throat,” he told the newspaper. After taking Paxlovid, he was “surprised and disappointed” to see he tested positive again, and he had symptoms such as a low fever, achiness, runny nose, and “mild cough.” He then called his doctor, who prescribed another 5-day course of Paxlovid, which Fauci said is relatively common among those who have a rebound.
…
Earlier this month, Pfizer, the maker of Paxlovid, announced that it would stop adding new people to a clinical trial of the drug among COVID-19 patients who have a low risk of hospitalization and death. The study failed to show that the drug reduced symptoms, hospitalizations, or deaths in a statistically significant way, Bloomberg reported.

COVID-19 Rebound After Paxlovid Treatment:

There is currently no evidence that additional treatment is needed with Paxlovid or other anti-SARS-CoV-2 therapies in cases where COVID-19 rebound is suspected.

Going against CDC guidance, huh?! Hypocrite!

Why America Doesn’t Trust the CDC

June 13, 2022June 13, 2022 Tina Marie (Ms. Cat)

Why America Doesn’t Trust the CDC

Most remarkably, it didn’t seem to matter to the CDC that 75.2 percent of children under age 11 already have natural immunity, according to a CDC study that concluded in February. Natural immunity is certainly much more prevalent today, given the ubiquity of the Omicron variant since February. CDC data from New York and California demonstrated that natural immunity was 2.8 times more effective in preventing hospitalization and 3.3 to 4.7 times more effective in preventing COVID infection compared to vaccination during the Delta wave. These findings are consistent with dozens of other clinical studies. Yet natural immunity has consistently and inexplicably been dismissed by the medical establishment.
…
Public health officials are expected to recommend COVID vaccines for children under 5 as soon as June 21st, despite the fact that the vast majority of children already have natural immunity. In a recent Kaiser survey, only 18 percent of parents said they were eager to vaccinate their child in that age group.

Triple Jabbed Trudeau Tests Positive, Again, for Covid

June 13, 2022June 13, 2022 Tina Marie (Ms. Cat)

As I’d written the first time the poster boy for vaccine fail tested positive. Vaccine fail. In fact his positive testing follows along with all the other triple jabbed persons who have since contracted Covid, more then once. As reported by legacy media. As we’ve witnessed real world ourselves.
Triple Jabbed Trudeau Tests Positive, Again, for Covid

Boosted Americans Getting More Covid Infections

June 7, 2022June 7, 2022 Tina Marie (Ms. Cat)1 Comment

Why boosted Americans seem to be getting more COVID-19 infections
This past month (back to early May/22) I’m personally aware of numerous triple jabbed persons coming down with covid. Three shots and still getting infected. Clearly this is larger then my limited circle of acquaintances in Canada.
Boosted Americans Getting More Covid Infections

The C.D.C. will undergo a comprehensive re-evaluation, the agency’s director said.

April 5, 2022April 5, 2022 Tina Marie (Ms. Cat)

The C.D.C. will undergo a comprehensive re-evaluation, the agency’s director said.

But the agency’s infrastructure was neglected for decades, like the nation’s public health system generally, and the pandemic has posed unprecedented challenges. Early on, the C.D.C. made key mistakes in testing and surveillance — for example, famously fumbling design of a diagnostic kit sent to state laboratories.
Officials were late to recommend masking, partly because agency scientists didn’t recognize quickly that the virus was airborne. In May of last year, Dr. Walensky announced that vaccinated people could take masks off indoors and outdoors; just weeks later, it became clear that vaccinated people could not only get breakthrough infections but also could transmit the virus.
In August, Dr. Walensky joined President Biden in supporting booster shots for all Americans, before scientists at the Food and Drug Administration or her own agency had reviewed the data on whether they were needed.
More recently, the highly contagious Omicron variant has led the C.D.C. to issue recommendations based on what once would have been considered insufficient evidence, amid growing public concern about how these guidelines affect the economy and education.
In December, the C.D.C. shortened the isolation period for infected Americans to five days, although it appears that many infected people can transmit the virus for longer. Over the past few weeks, some experts have criticized the agency for changing the metrics used to assess risk and determine appropriate local measures, in order to appease business and political interests.

UPDATED: FDA is considering FOURTH dose of COVID-19 vaccine and making it an annual shot as cases across the US drop 43% over the past week and 87% since the peak of the Omicron variant

February 25, 2022February 25, 2022 Tina Marie (Ms. Cat)

FDA is considering FOURTH dose of COVID-19 vaccine and making it an annual shot as cases across the US drop 43% over the past week and 87% since the peak of the Omicron variant

A fourth booster shot of either the Pfizer or Moderna vaccine could start an annual booster shot campaign, one of the people familiar with the FDA’s planning said.